These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19804808)

  • 1. Effects of venlafaxine and fluoxetine on lymphocyte subsets in patients with major depressive disorder: a flow cytometric analysis.
    Başterzi AD; Yazici K; Buturak V; Cimen B; Yazici A; Eskandari G; Tot Acar S; Taşdelen B
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):70-5. PubMed ID: 19804808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
    Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine once every third day in the treatment of major depressive disorder.
    Tural U; Onder E
    Eur Arch Psychiatry Clin Neurosci; 2003 Dec; 253(6):307-12. PubMed ID: 14714120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference in pre- and post-treatment plasma DHEA levels were significantly and positively correlated with difference in pre- and post-treatment Hamilton depression scores following successful therapy for major depression.
    Hsiao CC
    Psychoneuroendocrinology; 2006 Aug; 31(7):839-46. PubMed ID: 16716529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte subsets in treatment-resistant major depression.
    Kubera M; Van Bockstaele D; Maes M
    Pol J Pharmacol; 1999; 51(6):547-9. PubMed ID: 10817536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study.
    Akkaya C; Sivrioglu EY; Akgoz S; Eker SS; Kirli S
    Hum Psychopharmacol; 2006 Jul; 21(5):337-45. PubMed ID: 16856215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin transporter is differentially localized in subpopulations of lymphocytes of major depression patients. Effect of fluoxetine on proliferation.
    Fazzino F; Montes C; Urbina M; Carreira I; Lima L
    J Neuroimmunol; 2008 May; 196(1-2):173-80. PubMed ID: 18462811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?
    Amsterdam JD; Shults J
    J Affect Disord; 2009 May; 115(1-2):234-40. PubMed ID: 18694599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two-color flow cytometry analysis of lymphocyte subsets in patients with acute myocardial infarction and post-myocardial infarction syndrome].
    Tsuchihashi M; Sakaguchi Y; Nakamura M; Sutani T; Tsuruta S; Kato S; Uemura S; Nishida Y; Hashimoto T; Kagoshima T
    J Cardiol; 1995 Aug; 26(2):69-79. PubMed ID: 7674146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of an acute antidepressant response to fluoxetine and sertraline.
    Flament MF; Lane RM; Zhu R; Ying Z
    Int Clin Psychopharmacol; 1999 Sep; 14(5):259-75. PubMed ID: 10529069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte subsets and viral load in male AIDS patients with major depression: naturalistic study.
    Huang TL; Leu HS; Liu JW
    Psychiatry Clin Neurosci; 2006 Dec; 60(6):687-92. PubMed ID: 17109702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hopelessness as a predictor of non-response to fluoxetine in major depressive disorder.
    Papakostas GI; Petersen T; Homberger CH; Green CH; Smith J; Alpert JE; Fava M
    Ann Clin Psychiatry; 2007; 19(1):5-8. PubMed ID: 17453655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the immune system activity in Iranian patients with Major Depression Disorder (MDD).
    Farid Hosseini R; Jabbari Azad F; Talaee A; Miri S; Mokhber N; Farid Hosseini F; Esmaeili H; Mahmoudi M; Rafatpanah H; Mohammadi M
    Iran J Immunol; 2007 Mar; 4(1):38-43. PubMed ID: 17652842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical profiles of circulating dendritic cell phenotype and lymphocyte subsets in patients chronically infected with HBV during lamivudine treatment].
    Li HW; Wang HF; Wang FS; Jin B; Duan XZ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):43-6. PubMed ID: 16642218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of flow cytometry in evaluation of cellular changes in interstitial lung diseases].
    Kopiński P
    Folia Med Cracov; 1997; 38(3-4):69-115. PubMed ID: 10481384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte subsets and specific T-cell immune response in thalassemia.
    Pattanapanyasat K; Thepthai C; Lamchiagdhase P; Lerdwana S; Tachavanich K; Thanomsuk P; Wanachiwanawin W; Fucharoen S; Darden JM
    Cytometry; 2000 Feb; 42(1):11-7. PubMed ID: 10679738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.